By: Ryan Mueller
The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant milestone in the tobacco industry's efforts to offer alternatives to traditional smoking products. The decision, announced Thursday, follows an extensive scientific review, with regulators highlighting potential health benefits for adult smokers while facing criticism over the product's potential appeal to minors.